Publicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (18)

2024

  1. Impact of Pleural Lavage Cytology Positivity on Early Recurrence After Surgery for Non-Small Cell Lung Cancer

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 133-142

  2. Main Types of Cysts in Dermatopathology: Part 1

    Revista Espanola de Patologia, Vol. 57, Núm. 1, pp. 27-41

  3. Main Types of Cysts in Dermatopathology: Part 2

    Revista Espanola de Patologia, Vol. 57, Núm. 2, pp. 97-110

2021

  1. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occlusion — Part I: Thrombi

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 1, pp. 1-13

  2. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occusion — Part II: Coagulation Disorders, Emboli, and Other

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 2, pp. 103-117

  3. Granulomas in Dermatopathology: Principal Diagnoses - Part 1

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 8, pp. 682-704

  4. Granulomas in Dermatopathology: Principal Diagnoses — Part 2

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 8, pp. 705-724

2020

  1. Lat-1 and glut-1 carrier expression and its prognostic value in gastroenteropancreatic neuroendocrine tumors

    Cancers, Vol. 12, Núm. 10, pp. 1-18

2018

  1. Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors

    Scientific Reports, Vol. 8, Núm. 1

  2. Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 815-826

  3. Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia

  4. Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology (Clinical and Translational Oncology, (2018), 20, 7, (815-826), 10.1007/s12094-017-1800-5)

    Clinical and Translational Oncology

2012

  1. Usefulness of material recovered from distal embolic protection devices after carotid angioplasty for proteomic studies

    Journal of Vascular and Interventional Radiology, Vol. 23, Núm. 6, pp. 818-824

2011

  1. Somatotroph tumor progression during pegvisomant therapy: A clinical and molecular study

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 2

2010

  1. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

2009

  1. Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert's syndrome

    European Journal of Endocrinology, Vol. 160, Núm. 5, pp. 869-872

2003

  1. Physiopathology of the atherosclerotic plaque and imaging methods findings

    Radiologia, Vol. 45, Núm. 3, pp. 107-114

1997

  1. An Octamer Element Functions as a Regulatory Element in the Differentiation-Responsive CD11c Integrin Gene Promoter: OCT-2 Inducibility during Myelomonocytic Differentiation

    Journal of Immunology, Vol. 158, Núm. 12, pp. 5833-5840